(Q43182895)

15 November 2017

title

Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib (English)

1 reference

15 November 2017

1 reference

Martijn R Meijerink

4

0 references

Christian U Blank

series ordinal

3

object named as

Christian Blank

1 reference

15 November 2017

6

John B A G Haanen

1 reference

15 November 2017

Axel Bex

1

1 reference

15 November 2017

Astrid A M Van der Veldt

series ordinal

2

1 reference

15 November 2017

Epie Boven

series ordinal

5

1 reference

15 November 2017

language of work or name

1 reference

1 May 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

49

1 reference

15 November 2017

issue

4

1 reference

15 November 2017

page(s)

520-523

1 reference

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Sunitinib for treatment of advanced renal cell cancer: primary tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Treatment with sunitinib enabled complete resection of massive lymphadenopathy not previously amenable to excision in a patient with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Thrombotic events in patients with cancer receiving antiangiogenesis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Cytoreductive nephrectomy in the era of targeted molecular agents: is it time to consider presurgical systemic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903521111

10.3109/02841860903521111

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference